A simple electrophoretic method for phenotyping Apo(a): Phenotype frequency in healthy subjects from Paris, France

Clinical Chemistry

Volumn 44, Issue 5, 1998, Pages 1047-1050

  Couderc, R ^a   Peoc'h, K ^a   Valenti, K ^b   Diop, M E ^a   Bailleul, S ^a   Kienou L ^a   Ferriere F ^c   Etienne, J ^a  

^a HÔPITAL TENON   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; LIPOPROTEIN A; TETRANECTIN;

ARTICLE; ATHEROSCLEROSIS; CALIBRATION; HUMAN; HUMAN EXPERIMENT; IMMUNOELECTROPHORESIS; KRINGLE DOMAIN; MOLECULAR WEIGHT; NORMAL HUMAN; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN POLYMORPHISM; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SEQUENCE HOMOLOGY;

EID: 0031946910     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.5.1047     Document Type: Article

References (21)

1. Furbee J, Fless G. Evaluation of common electrophoretic methods in determining the molecular weight of apo(a) polymorphs. Anal Biochem 1993;234:66-73.
2. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein (a). Hum Mol Genet 1993;2:933-40.
3. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989;339:303-5.
4. Kraft HG, Lingenhel A, Kochl S, Hoppichler F, Kronenberg F, Abe A, et al. Apolipoprotein (a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996;16:713-9.
5. Hervio H, Durlach V, Girard-Globa A, Anglés-Cano E. Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis. Biochemistry 1995;34:13353-8.
6. Lackner C, Boerwinkle E, Leffert C, Rhamig T, Hobbs H. Molecular basis of apo(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991;87:2153-61.
7. Kamboh M, Ferrell R, Kottke B. Expressed hypervariable polymorphism of apo(a). Am J Hum Genet 1991;49:1063-74.
8. Utermann G, Kraft HG, Menzel HJ, Hopferwieser T, Seitz C. Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet 1988;74: 41-6.
9. Kraft H, Dieplinger H, Hoye E, Utermann G. Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Atherosclerosis 1988; 8:212-6.
10. Csako G, Nagy B, Costello R, Costelli J, Hruskewycz A. Pulsed-field gel electrophoresis for the separation of large protein molecules exemplified by the isoforms of apo(a). Electrophoresis 1994;15:926-9.
11. Huang C, Kraft H, Gregg R. Modified immunoblotting technique for phenotyping lipoprotein (a). Clin Chem 1991;37:576-8.
12. Craig W, Poulin S, Ledue T, Kamboh M. Apo(a): a comparison of isoforms identified by SDS-polyacrylamide gel electrophoresis or by SDS-agarose gel electrophoresis. Electrophoresis 1993;14:1038-41.
13. Marcovina S, Zhang Z, Gaus V, Albers J. Identification of 34 apolipoprotein (a) isoforms: differential expression of apo(a) alleles between American blacks and whites. Biochem Biophys Res Com 1991;191:1192-6.
14. Kraft HG, Lingenhel A, Bader G, Kostner GM, Utermann G. The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 1996; 125:53-61.
15. Valenti K, Aveynier E, Laporte F, Hadjian AJ. Evaluation of the genotyping and phenotyping approaches in the investigation of apolipoprotein (a) size polymorphism. Clin Chim Acta 1997;263:249-60.
16. Marcovina SM, Hobbs HH, Albers JJ. Relation between number of apolipoprotein (a) kringle 4 repeats and mobility of isoforms in agarose gel: bases for a standardized isoform nomenclature. Clin Chem 1996;42: 436-9.
17. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson G, Boerwinkle E, Utermann G. Relation of serum Lp(a) concentration and apo(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990;322:1494-9.
18. Mölgaard J, Klausen C, Lassvik C, Faergeman O, Gerdes LU, Olsson A. Significant association between low-molecular weight apolipoprotein(a) isoforms and intermittent claudication. Arterioscler Thromb 1992;12:895-901.
19. Klausen IC, Gerdes LU, Schmidt EB, Dyerberg J, Faergeman O. Differences in apolipoprotein (a) polymorphism in west Greenland Eskimos and Cauca sian Danes. Hum Genet 1992;89:384-8.
20. Bigot E, Robert B, Bard JM, Mainard F. Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentration. Clin Chim Acta 1997;265:99-111.
21. Marcovina SM, Albers JJ, Jacobs DR, Perkins LL, Lewis CE, Howard BV, Savage P. Lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in Caucasians and African Americans. The CARDIA study. Arterioscler Thromb 1993;13:1037-45.